A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity
Public ClinicalTrials.gov record NCT06693843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity (Body Mass Index ≥ 30 kg/m2) or Overweight (Body Mass Index ≥ 27 kg/m2) With at Least One Weight-related Comorbidity
Study identification
- NCT ID
- NCT06693843
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Industry
- Enrollment
- 220 participants
Conditions and interventions
Interventions
- Aleniglipron Drug
- Aleniglipron or Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 79 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 27, 2024
- Primary completion
- Oct 23, 2025
- Completion
- Jul 31, 2026
- Last update posted
- Apr 27, 2026
2024 – 2026
United States locations
- U.S. sites
- 39
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ACCESS Research Site | Phoenix | Arizona | 85044 | — |
| ACCESS Research Site | Anaheim | California | 92801 | — |
| ACCESS Research Site | Los Angeles | California | 90057 | — |
| ACCESS Research Site | Montclair | California | 91763 | — |
| ACCESS Research Site | Rancho Cucamonga | California | 91730 | — |
| ACCESS Research Site | Sacramento | California | 95821 | — |
| ACCESS Research Site | Spring Valley | California | 91978 | — |
| ACCESS Research Site | Honolulu | Hawaii | 96814 | — |
| ACCESS Research Site | Chicago | Illinois | 60602 | — |
| ACCESS Research Site | Chicago | Illinois | 60637 | — |
| ACCESS Research Site | Evanston | Illinois | 60201 | — |
| ACCESS Research Site | Muncie | Indiana | 47304 | — |
| ACCESS Research Site | Valparaiso | Indiana | 46383 | — |
| ACCESS Research Site | West Des Moines | Iowa | 50265 | — |
| ACCESS Research Site | Baton Rouge | Louisiana | 70808 | — |
| ACCESS Research Site | Richfield | Minnesota | 55423 | — |
| ACCESS Research Site | City of Saint Peters | Missouri | 63303 | — |
| ACCESS Research Site | Hazelwood | Missouri | 63042 | — |
| ACCESS Research Site | Springfield | Missouri | 65807 | — |
| ACCESS Research Site | Albany | New York | 12203 | — |
| ACCESS Research Site | Binghamton | New York | 13905 | — |
| ACCESS Research Site | Brooklyn | New York | 10016 | — |
| ACCESS Research Site | Rochester | New York | 14609 | — |
| ACCESS Research Site | Wilmington | North Carolina | 28403 | — |
| ACCESS Research Site | Cincinnati | Ohio | 45219 | — |
| ACCESS Research Site | Norman | Oklahoma | 73069 | — |
| ACCESS Research Site | Medford | Oregon | 97504 | — |
| ACCESS Research Site | Pittsburgh | Pennsylvania | 15236 | — |
| ACCESS Research Site | Moncks Corner | South Carolina | 29461 | — |
| ACCESS Research Site | Chattanooga | Tennessee | 37421 | — |
| ACCESS Research Site | Austin | Texas | 78704 | — |
| ACCESS Research Site | Austin | Texas | 78731 | — |
| ACCESS Research Site | Dallas | Texas | 75226 | — |
| ACCESS Research Site | Dallas | Texas | 75243 | — |
| ACCESS Research Site | Mesquite | Texas | 75149 | — |
| ACCESS Research Site | Shavano Park | Texas | 78231 | — |
| ACCESS Research Site | West Jordan | Utah | 84088 | — |
| ACCESS Research Site | Winchester | Virginia | 22601 | — |
| ACCESS Research Site | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06693843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06693843 live on ClinicalTrials.gov.